[PDF][PDF] iPSC-derived retina transplants improve vision in rd1 end-stage retinal-degeneration mice

M Mandai, M Fujii, T Hashiguchi, GA Sunagawa, S Ito… - Stem cell reports, 2017 - cell.com
M Mandai, M Fujii, T Hashiguchi, GA Sunagawa, S Ito, J Sun, J Kaneko, J Sho, C Yamada…
Stem cell reports, 2017cell.com
Recent success in functional recovery by photoreceptor precursor transplantation in
dysfunctional retina has led to an increased interest in using embryonic stem cell (ESC) or
induced pluripotent stem cell (iPSC)-derived retinal progenitors to treat retinal degeneration.
However, cell-based therapies for end-stage degenerative retinas that have lost the outer
nuclear layer (ONL) are still a big challenge. In the present study, by transplanting mouse
iPSC-derived retinal tissue (miPSC retina) in the end-stage retinal-degeneration model …
Summary
Recent success in functional recovery by photoreceptor precursor transplantation in dysfunctional retina has led to an increased interest in using embryonic stem cell (ESC) or induced pluripotent stem cell (iPSC)-derived retinal progenitors to treat retinal degeneration. However, cell-based therapies for end-stage degenerative retinas that have lost the outer nuclear layer (ONL) are still a big challenge. In the present study, by transplanting mouse iPSC-derived retinal tissue (miPSC retina) in the end-stage retinal-degeneration model (rd1), we visualized the direct contact between host bipolar cell terminals and the presynaptic terminal of graft photoreceptors by gene labeling, showed light-responsive behaviors in transplanted rd1 mice, and recorded responses from the host retina with transplants by ex vivo micro-electroretinography and ganglion cell recordings using a multiple-electrode array system. Our data provides a proof of concept for transplanting ESC/iPSC retinas to restore vision in end-stage retinal degeneration.
cell.com